pennews
www.pennews.net
Aleor Dermaceuticals receives EIR from USFDA
Business

Aleor Dermaceuticals receives EIR from USFDA

Agency News

Mumbai, May 6: Aleor Dermaceuticals Ltd (Aleor), a 60:40 Joint Venture between Alembic Pharmaceuticals Ltd (Alembic) and Orbicular Pharmaceutical Technologies Pvt Ltd (Orbicular), has received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA).

The EIR is for the inspection carried out by USFDA at Aleor's Formulation Facility at Karakhadi, Gujarat, India during the period from February 4, 2019 to February 8, 2019, Alembic Pharma said in a filing with BSE. (UNI)